An extracellular matrix fragment drives epithelial remodeling and airway hyper-responsiveness
File(s)aaq0693_combined document.pdf (4.06 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
It is anticipated that bioactive fragments of the extracellular matrix (matrikines) can influence the development and progression of chronic diseases. The enzyme leukotriene A4 hydrolase (LTA4H) mediates opposing proinflammatory and anti-inflammatory activities, through the generation of leukotriene B4 (LTB4) and degradation of proneutrophilic matrikine Pro-Gly-Pro (PGP), respectively. We show that abrogation of LTB4 signaling ameliorated inflammation and airway hyperresponsiveness (AHR) in a murine asthma model, yet global loss of LTA4H exacerbated AHR, despite the absence of LTB4. This exacerbated AHR was attributable to a neutrophil-independent capacity of PGP to promote pathological airway epithelial remodeling. Thus, we demonstrate a disconnect between airway inflammation and AHR and the ability of a matrikine to promote an epithelial remodeling phenotype that negatively affects lung function. Subsequently, we show that substantial quantities of PGP are detectable in the sputum of moderate-severe asthmatics in two distinct cohorts of patients. These studies have implications for our understanding of remodeling phenotypes in asthma and may rationalize the failure of LTA4H inhibitors in the clinic.
Date Issued
2018-08-22
Date Acceptance
2018-07-20
Citation
Science Translational Medicine, 2018, 10 (455), pp.1-13
ISSN
1946-6234
Publisher
American Association for the Advancement of Science
Start Page
1
End Page
13
Journal / Book Title
Science Translational Medicine
Volume
10
Issue
455
Copyright Statement
© 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.
Sponsor
Wellcome Trust
Asthma UK
Wellcome Trust
Wellcome Trust
Wellcome Trust
Medical Research Council (MRC)
Medical Research Council (MRC)
Medical Research Council (MRC)
Grant Number
095707/Z/11/Z
AUK-IG-2014-286
209458/Z/17/Z
209458/Z/17/Z
107059/Z/15/Z
G1000758
G1000758
MC_PC_13064
Subjects
Science & Technology
Life Sciences & Biomedicine
Cell Biology
Medicine, Research & Experimental
Research & Experimental Medicine
LEUKOTRIENE A(4) HYDROLASE
OBSTRUCTIVE PULMONARY-DISEASE
PROLINE-GLYCINE-PROLINE
NEUTROPHILIC INFLAMMATION
SEVERE ASTHMA
INDUCED SPUTUM
LUNG
B-4
CHEMOATTRACTANT
INHIBITOR
Airway Remodeling
Airway Resistance
Animals
Asthma
Bronchi
Cell Count
Disease Models, Animal
Epithelial Cells
Epoxide Hydrolases
Extracellular Matrix
Humans
Hypersensitivity
Inflammation
Inflammation Mediators
Mice, Inbred C57BL
Mucus
Neutrophils
Oligopeptides
Proline
Pyroglyphidae
Respiratory Hypersensitivity
Sputum
T-Lymphocytes, Helper-Inducer
Bronchi
Neutrophils
T-Lymphocytes, Helper-Inducer
Extracellular Matrix
Epithelial Cells
Mucus
Sputum
Animals
Mice, Inbred C57BL
Humans
Pyroglyphidae
Asthma
Respiratory Hypersensitivity
Hypersensitivity
Disease Models, Animal
Inflammation
Epoxide Hydrolases
Proline
Oligopeptides
Inflammation Mediators
Airway Resistance
Cell Count
Airway Remodeling
06 Biological Sciences
11 Medical and Health Sciences
Publication Status
Published
Article Number
ARTN eaaq0693